CompletedPhase 3NCT02684708
Second International Inter-Group Study for Classical Hodgkin Lymphoma in Children and Adolescents
Studying Hodgkin lymphoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Giessen
- Principal Investigator
- Dieter Koerholz, MDJustus-Liebig University of Giessen
- Intervention
- cyclophosphamide, vincristine, prednisone, dacarbazine(drug)
- Enrollment
- 2921 enrolled
- Eligibility
- 25 years · All sexes
- Timeline
- 2015 – 2025
Study locations (19)
- Royal Children's Hospital and Monash Medical Centre Royal Children's Hospital, Victoria Park, Australia
- St. Anna Kinderspital, Vienna, Austria
- Paediatric haemato-oncology, University Hospitals of Leuven, Leuven, Belgium
- Dpt. of Pediatric Hematology and Oncology, Faculty Hospital Motol, Prague, Czechia
- Department of Pediatric Hematology/Oncology (5054) The Child and Youth Clinic, University Hospital of Copenhagen, Copenhagen, Denmark
- Service d'Oncohématologie, Hopital d'Ènfants Armand Trousseau, Paris, France
- Justus Liebig University of Giessen, Giessen, Germany
- Our Lady's Children's Hospital, Crumlin, Dublin, Ireland
- Tel Aviv University Schneider Children's Medical Center of Israel The Rina Zaizov Pediatric Hematology Oncology Division, Petah Tikva, Israel
- Pediatric Radiotherapy and Youth Area Unit C.R.O. - Centro di Riferimento Oncologico IRCCS, Aviano, Italy
- Princess Máxima Center for pediatric oncology, Utrecht, Netherlands
- Starship Blood and Cancer Centre, Starship Children's Hospital, Auckland, New Zealand
- Department of Medical Oncology Oslo University Hospital, Oslo, Norway
- Head of Department of Pediatric Oncology and Hematology, Polish-American Pediatric Institute, Jagiellonian University Medical Faculty, Krakow, Poland
- Clinic of Pediatric Oncology University Children's Hospital, Bratislava, Slovakia
- +4 more locations on ClinicalTrials.gov
Collaborators
Deutsche Krebshilfe e.V., Bonn (Germany) · Euronet Worldwide
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02684708 on ClinicalTrials.govOther trials for Hodgkin lymphoma
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGNCT07374068Prognostic Model of Elderly Hodgkin Lymphoma in ChinaTianjin Medical University Cancer Institute and Hospital
- RECRUITINGNCT07356882European Project for ctDNA Detection as a Biomarker for Non-invasive Therapy Monitoring in Paediatric Classical Hodgkin LymphomaAssistance Publique - Hôpitaux de Paris
- RECRUITINGPHASE2NCT06848569Sintilimab Plus AVD in Pediatric Low/Moderate Risk Hodgkin Lymphoma: A Phase II StudySun Yat-sen University
- RECRUITINGPHASE2, PHASE3NCT06563245Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT AssessmentChildren's Cancer Group, China
- RECRUITINGPHASE2NCT04838652Pembrolizumab in Combination With Salvage Chemotherapy for First-relapsed or Refractory Classical Hodgkin LymphomaUniversity of Cologne
- RECRUITINGPHASE2NCT05900765A Study of Zimberelimab(GLS-010) Combined With AVD for Newly Diagnosed Early-stage Hodgkin's LymphomaSun Yat-sen University
- RECRUITINGNCT06822855Changing Paragidms In The Prognostic Assessment Of Hodgkin LymphomaAzienda USL Reggio Emilia - IRCCS
- ACTIVE NOT RECRUITINGPHASE1NCT04640779Low-Dose Selinexor and Choline Salicylate for Non-Hodgkin or Hodgkin Lymphoma, Histiocytic/Dendritic Cell Neoplasm, or Relapsed or Refractory Multiple MyelomaMayo Clinic